Northwestern Mutual Investment Management Company LLC Has $7.84 Million Stake in UnitedHealth Group Inc (NYSE:UNH)

Northwestern Mutual Investment Management Company LLC boosted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 36,089 shares of the healthcare conglomerate’s stock after buying an additional 42 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in UnitedHealth Group were worth $7,843,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Garrison Point Advisors LLC grew its position in shares of UnitedHealth Group by 1.2% in the second quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock valued at $851,000 after purchasing an additional 40 shares during the last quarter. Clear Harbor Asset Management LLC grew its position in shares of UnitedHealth Group by 0.6% in the third quarter. Clear Harbor Asset Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock valued at $1,428,000 after purchasing an additional 40 shares during the last quarter. Smith Moore & CO. grew its position in shares of UnitedHealth Group by 1.3% in the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock valued at $770,000 after purchasing an additional 41 shares during the last quarter. Integrated Investment Consultants LLC grew its position in shares of UnitedHealth Group by 3.9% in the second quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 42 shares during the last quarter. Finally, Meridian Financial Partners LLC grew its position in shares of UnitedHealth Group by 2.7% in the second quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock valued at $403,000 after purchasing an additional 43 shares during the last quarter. 85.75% of the stock is currently owned by hedge funds and other institutional investors.

Several brokerages have recently issued reports on UNH. Oppenheimer set a $312.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target on the stock in a research report on Monday, July 22nd. Mizuho began coverage on UnitedHealth Group in a research report on Thursday, October 17th. They issued a “buy” rating and a $270.00 price target on the stock. UBS Group lowered their price target on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating on the stock in a research report on Thursday, October 17th. Finally, BMO Capital Markets downgraded UnitedHealth Group from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $292.00 to $249.00 in a research report on Monday, September 30th. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $283.84.

UNH stock traded down $1.68 during trading on Wednesday, reaching $253.57. 3,283,120 shares of the stock were exchanged, compared to its average volume of 4,520,105. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a market capitalization of $243.46 billion, a P/E ratio of 19.69, a price-to-earnings-growth ratio of 1.36 and a beta of 0.61. The stock has a 50 day simple moving average of $236.19 and a 200-day simple moving average of $241.50. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The business had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. During the same period last year, the business earned $3.41 earnings per share. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Inc will post 14.96 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 2,000 shares of the business’s stock in a transaction on Wednesday, August 28th. The stock was purchased at an average price of $227.55 per share, for a total transaction of $455,100.00. Following the completion of the purchase, the director now directly owns 5,524 shares in the company, valued at $1,256,986.20. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,177 shares of company stock worth $7,842,582. 0.82% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is a stock portfolio tracker?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.